Stemtech Corporation
OTC: STEK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Charles S. Arnold
- Employees
- 1
- Headquarters
- Naples, United States
- IPO year
- 2021
- Market cap
- $14.6K
- Website
- https://www.stemtech.com
Loading STEK…
Loading profile data…Frequently asked questions about STEK
What does Stemtech Corporation (STEK) do?
Stemtech Corporation is a pioneering company specializing in stem cell nutrition. It formulates scientifically-backed products designed to optimize the body's intrinsic stem cell physiology. With a market presence spanning the Americas, Latin America, and Asia, its offerings are engineered to bolster the natural functions of the body's stem cell...
Where does STEK trade?
Stemtech Corporation (STEK) trades on the Other OTC.
What sector is STEK in?
Stemtech Corporation (STEK) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Stemtech Corporation?
Charles S. Arnold is the chief executive officer of Stemtech Corporation (STEK).
Where is Stemtech Corporation headquartered?
Stemtech Corporation is headquartered in United States.
Does STEK pay a dividend?
Stemtech Corporation (STEK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did STEK go public?
Stemtech Corporation (STEK) completed its initial public offering in 2021.